Parkman Healthcare Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History

Parkman Healthcare Partners’s Portfolio LXRX Stock Details LXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$1.24M	Sell
2023 Q2	$3.05M	Buy
2023 Q1	$1.64M	Buy
2022 Q4	$804K	Buy
2022 Q3	$729K	Buy
2022 Q2	$465K	Buy